OCA

Octagon Capital Advisors Portfolio holdings

AUM $456M
1-Year Est. Return 48.55%
This Quarter Est. Return
1 Year Est. Return
+48.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$375M
AUM Growth
-$87.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$20.9M
2
+$18.3M
3
+$13.9M
4
APLS icon
Apellis Pharmaceuticals
APLS
+$11M
5
RCUS icon
Arcus Biosciences
RCUS
+$4.56M

Top Sells

1
+$14.5M
2
+$12.1M
3
+$9.6M
4
SURF
Surface Oncology, Inc. Common Stock
SURF
+$6.76M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$6.52M

Sector Composition

1 Healthcare 95.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$117M 31.17%
2,583,059
+243,000
2
$67.7M 18.06%
2,669,974
+180,000
3
$44.6M 11.91%
2,551,703
+1,195,453
4
$26.3M 7.02%
330,000
+230,000
5
$23.1M 6.16%
2,758,069
+194,931
6
$20.5M 5.48%
761,398
7
$18.1M 4.82%
243,400
+187,600
8
$10.1M 2.69%
763,456
-50,000
9
$8.48M 2.26%
933,743
-1,333,743
10
$7.83M 2.09%
575,000
11
$7.51M 2.01%
178,500
12
$4.67M 1.25%
321,641
13
$4.42M 1.18%
632,745
-934,150
14
$4.21M 1.12%
152,249
-187,965
15
$2.26M 0.6%
199,876
-849,815
16
$2.26M 0.6%
579,061
-895,939
17
$2.26M 0.6%
80,000
18
$2.18M 0.58%
260,000
-398,266
19
$1.12M 0.3%
+1,000,000
20
$325K 0.09%
122,800
-26,600
21
– –
-279,921
22
– –
-525,284
23
– –
-2,300,000
24
– –
-450,776
25
– –
-176,470